Cole, Andrew
Chege, Timothy
Aman, Rashid
Githuka, George
Muga, Richard
Aspinall, Adam
Kokwaro, Gilbert
Funding for this research was provided by:
Medicines for Malaria Venture (PO20/00538)
Article History
Received: 7 April 2025
Accepted: 12 September 2025
First Online: 10 October 2025
Declarations
:
: Written informed consent was obtained from all individual participants included in the study. For participants under 18 years of age, written informed consent was obtained from parents or legal guardians. All participants were informed of the study objectives, procedures, potential risks and benefits, and their right not to participate in the study without any effect on their care. The consent process was conducted in the English, Kiswahili, and Dholuo languages as preferred by the participants and all questions were answered before participation commenced.
: The authors declare no competing interests.